Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Smoot

Showing results (161-170 of 180) with videos related to

Pageof 18
Sort By:
Communications Biology|July 19, 2024
Diversity of post-translational modifications and cell signaling revealed by single cell and single organelle mass spectrometryDong-Gi Mun, Firdous A Bhat, Neha Joshi, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
Multiomics-driven discovery of predictive biomarkers and strategies to overcome resistance to SFK-YAP inhibition in cholangiocarcinomaHendrien Kuipers, Danielle M Carlson, Erik Jessen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
Redefining Upfront Resectable Pancreatic Ductal Adenocarcinoma: Should Vein Abutment Matter?Po Hong Tan, Cornelius A Thiels, Katherine Poruk, et al.
Gastro Hep Advances|August 12, 2024
Pancreatic Cancer is More Frequently Early Stage at Diagnosis in Surgically Resected Intraductal Papillary Mucinous Neoplasms With Preoperative SurveillanceJaime de la Fuente, Jacob Lui, Ryan J Lennon, et al.
JHEP Reports : Innovation in Hepatology|June 17, 2024
Metabolome-wide association identifies altered metabolites and metabolic pathways in the serum of patients with cholangiocarcinomaLinsey E Jackson, Jennifer L Tomlinson, Roberto Alva-Ruiz, et al.
Frontiers in Oncology|May 28, 2021
Predicting Adverse Pathologic Features and Clinical Outcomes of Resectable Pancreas Cancer With Preoperative CA 19-9Roman O Kowalchuk, Scott C Lester, Rondell P Graham, et al.
Annals of Surgical Oncology|March 11, 2025
Molecular KRAS ctDNA Predicts Metastases and Survival in Pancreatic Cancer: A Prospective Cohort StudyJennifer L Leiting, Roberto Alva-Ruiz, Jennifer A Yonkus, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 7, 2019
Safety, Diagnostic Accuracy, and Effects of Endoscopic Ultrasound Fine-Needle Aspiration on Detection of Extravascular Migratory MetastasesTarun Rustagi, Ferga C Gleeson, Suresh T Chari, et al.
Journal of Surgical Oncology|June 2, 2026
Enhanced Molecular Staging of Pancreatic Cancer Using Methylated DNA Markers in Peritoneal Lavage FluidKrystal Mills, Calise K Berger, William R Taylor, et al.
Journal of Hepatology|September 26, 2022
LCK inhibition downregulates YAP activity and is therapeutic in patient-derived models of cholangiocarcinomaCaitlin B Conboy, Jennifer A Yonkus, EeeLN H Buckarma, et al.
Pageof 18

Showing results (161-170 of 180) with videos related to

Sort By:
Pageof 18
Communications Biology|July 19, 2024
Diversity of post-translational modifications and cell signaling revealed by single cell and single organelle mass spectrometryDong-Gi Mun, Firdous A Bhat, Neha Joshi, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
Multiomics-driven discovery of predictive biomarkers and strategies to overcome resistance to SFK-YAP inhibition in cholangiocarcinomaHendrien Kuipers, Danielle M Carlson, Erik Jessen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
Redefining Upfront Resectable Pancreatic Ductal Adenocarcinoma: Should Vein Abutment Matter?Po Hong Tan, Cornelius A Thiels, Katherine Poruk, et al.
Gastro Hep Advances|August 12, 2024
Pancreatic Cancer is More Frequently Early Stage at Diagnosis in Surgically Resected Intraductal Papillary Mucinous Neoplasms With Preoperative SurveillanceJaime de la Fuente, Jacob Lui, Ryan J Lennon, et al.
JHEP Reports : Innovation in Hepatology|June 17, 2024
Metabolome-wide association identifies altered metabolites and metabolic pathways in the serum of patients with cholangiocarcinomaLinsey E Jackson, Jennifer L Tomlinson, Roberto Alva-Ruiz, et al.
Frontiers in Oncology|May 28, 2021
Predicting Adverse Pathologic Features and Clinical Outcomes of Resectable Pancreas Cancer With Preoperative CA 19-9Roman O Kowalchuk, Scott C Lester, Rondell P Graham, et al.
Annals of Surgical Oncology|March 11, 2025
Molecular KRAS ctDNA Predicts Metastases and Survival in Pancreatic Cancer: A Prospective Cohort StudyJennifer L Leiting, Roberto Alva-Ruiz, Jennifer A Yonkus, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 7, 2019
Safety, Diagnostic Accuracy, and Effects of Endoscopic Ultrasound Fine-Needle Aspiration on Detection of Extravascular Migratory MetastasesTarun Rustagi, Ferga C Gleeson, Suresh T Chari, et al.
Journal of Surgical Oncology|June 2, 2026
Enhanced Molecular Staging of Pancreatic Cancer Using Methylated DNA Markers in Peritoneal Lavage FluidKrystal Mills, Calise K Berger, William R Taylor, et al.
Journal of Hepatology|September 26, 2022
LCK inhibition downregulates YAP activity and is therapeutic in patient-derived models of cholangiocarcinomaCaitlin B Conboy, Jennifer A Yonkus, EeeLN H Buckarma, et al.
Pageof 18